Catalent is a leading global provider of advanced drug development and manufacturing solutions, helping pharmaceutical companies bring better treatments to market.

Catalent partners with pharmaceutical, biotech, and consumer health companies to optimise and accelerate the development, delivery, and supply of medicines, biologics, and health products. With a network of facilities worldwide and expertise in various delivery technologies, Catalent enhances product quality and expands access for patients globally.

Key Products and Services

• Drug Development Services: Preclinical to commercialisation support, including formulation and analytical services.
• Biologics: Advanced cell and gene therapy capabilities, protein therapies, and viral vector manufacturing.
• Drug Delivery Solutions: Expertise in oral, inhalation, injectable, and transdermal delivery technologies.
• Clinical Supply Services: Comprehensive support for clinical trials, including packaging and distribution.

Catalent’s mission to enhance patient care through innovative solutions makes it a trusted partner in the pharmaceutical and biotechnology industries. With state-of-the-art facilities, cutting-edge technologies, and a global reach, Catalent continues to shape the future of healthcare delivery.